Cite
HARVARD Citation
Yu, A. et al. (2021). Cost-effectiveness analyses of targeted therapy and immunotherapy for advanced non-small cell lung cancer in the United States: a systematic review. Expert review of pharmacoeconomics & outcomes research. pp. 381-393. [Online].